The Global Body Composition Analyzers Market Size will Hit $494 Million by 2027, at a CAGR of 4.2%

Body Composition Analyzers Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Body Composition Analyzers Market size is expected to reach $494 million by 2027, rising at a market growth of 4.2% CAGR during the forecast period.

The Bio-impedance Analyzer market acquired maximum revenue share in the Global Body Composition Analyzers Market by Product Type in 2020, achieving a market value of $203.3 million by 2027. This is owing to the low cost of bio-impedance analyzers, their ease of use, and greater accuracy over other body composition analyzers, as well as increased public awareness of healthy living.

The Fitness Clubs & Wellness Centers market shows high growth rate of 3.8 % during the forecast period. This is due to a rise in health consciousness, an increase in the number of gyms and fitness clubs, and an increase in the prevalence of obesity around the world. Moreover, the growth of the segment would be driven by the rise in government measures to promote a healthy lifestyle.

The North America market is generating high revenue in the Global Body Composition Analyzers Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $191.0 million by 2027. The Europe market is expected to witness a CAGR of 3.9% during (2021 - 2027). Additionally, The Asia Pacific market is expected to witness a CAGR of 4.9% during (2021 - 2027).

Full Report: https://www.kbvresearch.com/body-composition-analyzers-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Hologic, Inc., Omron Corporation, Bodystat Limited, COSMED Srl, InBody Co., Ltd., RJL Systems, Inc., SELVAS Healthcare (Selvas AI, Inc.), Tanita Corporation, and Seca GmbH & Co. Kg.

Global Body Composition Analyzers Market Segmentation

By Product Type

• Bio-impedance Analyzer
• Dual Energy X-ray Absorptiometry Equipment
• Skinfold Calipers
• Air Displacement Plethysmography Equipment, and
• Hydrostatic Weighing Equipment

By End User

• Fitness Clubs & Wellness Centers
• Hospitals, and
• Home Users

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• General Electric (GE) Co. (GE Healthcare)
• Hologic, Inc.
• Omron Corporation
• Bodystat Limited
• COSMED Srl
• InBody Co., Ltd.
• RJL Systems, Inc.
• SELVAS Healthcare (Selvas AI, Inc.)
• Tanita Corporation
• Seca GmbH & Co. Kg

Related Reports:

North America Body Composition Analyzers Market Size to 2027

• March-2022
• 59 Pages

LAMEA Body Composition Analyzers Market Size, Demand, 2027

• March-2022
• 68 Pages

Europe Body Composition Analyzers Market Size Report, 2027

• March-2022
• 68 Pages

Asia Pacific Body Composition Analyzers Market Size to 2027

• March-2022
• 69 Pages